LXR ligands induce apoptosis of EGFR-TKI-resistant human lung cancer cells in vitro by inhibiting Akt-NF-κB activation

Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are efficient in treating patients with non-small cell lung cancer (NSCLC) harboring EGFR activating mutations. Unfortunately, nearly all patients ultimately acquire resistance to EGFR-TKI treatment. Liver X receptors (LXRs) can...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncol Lett
Autores principales: Liu, Siwen, Cao, Haixia, Chen, Dan, Yu, Shaorong, Sha, Huanhuan, Wu, Jianzhong, Ma, Rong, Wang, Zhuo, Jing, Changwen, Zhang, Junying, Feng, Jifeng
Formato: Artigo
Lenguaje:Inglês
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5921072/
https://ncbi.nlm.nih.gov/pubmed/29731879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.8182
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares